Neuraxpharm Polskasp. z o.o.

Advertising agencies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-07-01
Share capital
5,000.00 PLN
Registered address
ul. Poleczki 35, 02-822 Warszawa, Poland

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$293,188

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 74 days for 2021). 3 of 6 audited by a statutory auditor.

  • 202515/07/2026
  • 202426/08/2025
  • 202320/06/2024
  • 202229/06/2023
  • 202127/09/2022
  • 202008/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 11.26mMedianUSD 115.58kAverageUSD 1.11m
Net profit
This companyUSD 839.51kMedianUSD 4.00kAverageUSD 74.63k
Operating costs
This companyUSD 10.06mMedianUSD 100.66kAverageUSD 1.01m
Assets
This companyUSD 4.73mMedianUSD 57.25kAverageUSD 667.35k

Authorized Representatives

Jacek Sawicki – Vice President of the Management Board
Maximilian Von Wulfing – President of the Management Board

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the President of the Management Board. In the case of a management board consisting of two or more persons, the President of the Management Board or the Vice-President of the Management Board is authorized individually, or two members of the management board, or one member of the management board jointly with a commercial proxy, to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Neuraxpharm Arzneimittel Gmbh
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-04-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Wandoo Financesp. z o.o.
Keino Grupasp. z o.o.
Screen NetworkS.A.
New Age Mediasp. z o.o.
Polymussp. z o.o.
CUBE GroupS.A.
IQ Marketingsp. z o.o.
Formupsp. z o.o.
AWEBsp. z o.o.
HHPsp. z o.o.

Change history

DateEvent
2021-11-17Address change
2019-07-01Entered in the register

FAQ

Last updated: 2026-10-14